Diagnostic value of endometrium associated with papillary metaplastic changes in endometrial cytopathology

Papillary metaplastic changes especially occur in both non‐neoplastic and neoplastic endometrium. We tried to investigate to assess the relationship between endometrial cytologic diagnosis and papillary metaplasia. The material consists of 160 cases of cytologic smears obtained by direct sampling of the endometrial cavity comprising 54 cases of normal proliferative endometrium (NPE), 36 cases of glandular and stromal breakdown (EGBD), and 70 cases of endometrial hyperplasia without atypia (EH). As for the correlation between the appearance of papillary metaplasia and cytological diagnosis, a statistical significance test was performed. The material consists of 40 cases of cytologic smears examined by direct sampling of the endometrial cavity comprising 10 cases of EGBD with papillary metaplasia, 10 cases of G1 without pappilary metaplasia, 10 cases of NPE without papillary metaplasia, and 10 cases of EH without papillary metaplasia. Using the comparison between appearance of papillary metaplasia and cytological diagnosis, a significant difference was only seen in the rate of correct diagnoses in EGBD cases. The nuclear area of papillary metaplastic cells in EGBD was 888.8, G1 was 928.7, NPE was 682.0, and EH was 722.2. Significant difference was observed between ECC cells in EGBD to NPE, between papillary metaplastic cells in EGBD to EH, between G1 to NPE, or between G1 to EH.

[1]  Y Norimatsu,et al.  New diagnostic reporting format for endometrial cytology based on cytoarchitectural criteria , 2009, Cytopathology : official journal of the British Society for Clinical Cytology.

[2]  E. Ohno,et al.  Endometrial glandular and stromal breakdown, part 2: Cytomorphology of papillary metaplastic changes , 2006, Diagnostic cytopathology.

[3]  E. Ohno,et al.  Endometrial glandular and stromal breakdown, part 1: Cytomorphological appearance , 2006, Diagnostic cytopathology.

[4]  Eiji Ohno,et al.  Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler , 2006, Cancer.

[5]  T. Nikaido,et al.  Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. , 2003, Human pathology.

[6]  R. Miranda,et al.  Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. , 2009, Archives of pathology & laboratory medicine.

[7]  H. Kuramoto,et al.  Effectiveness of Mass Screening for Endometrial Cancer , 2002, Acta Cytologica.

[8]  W. R. Hart,et al.  Simple and Complex Hyperplastic Papillary Proliferations of the Endometrium: A Clinicopathologic Study of Nine Cases of Apparently Localized Papillary Lesions With Fibrovascular Stromal Cores and Epithelial Metaplasia , 2001, The American journal of surgical pathology.

[9]  M. Nucci,et al.  Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[10]  W. Zheng,et al.  p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding , 1999, Histopathology.

[11]  F. Tavassoli,et al.  Oncocytic metaplasia and carcinoma of the endometrium: an immunohistochemical and ultrastructural study. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  T. Nikaido,et al.  Immunohistochemical Detection of Cyclin A with Reference to p53 Expression in Endometrial Endometrioid Carcinomas , 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[13]  Yazdi Hm,et al.  «Minimal deviation» endometrioid carcinoma with oncocytic change of the endometrium , 1995 .

[14]  W. Lawrence,et al.  Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[15]  M. Mazur,et al.  Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. , 1993, American journal of clinical pathology.

[16]  T. Kaku,et al.  Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  R. Kempson,et al.  Primary mucinous adenocarcinoma of the endometrium: A clinicopathologic and histochemical study* , 1983, The American journal of surgical pathology.

[18]  M. Hendrickson,et al.  Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma Report of 89 cases and proposed classification , 1980, The American journal of surgical pathology.

[19]  Z. Katz,et al.  Endocervical‐type epithelium in endometrial carcinoma: A report of 10 cases with emphasis on histochemical methods for differential diagnosis , 1980, The American journal of surgical pathology.

[20]  Ehrmann Rl.  Atypical endometrial cells and stromal breakdown two case reports. , 1975 .